Lexaria Bioscience (LEXX) Capital Leases (2022 - 2024)
Historic Capital Leases for Lexaria Bioscience (LEXX) over the last 3 years, with Q3 2024 value amounting to $109319.0.
- Lexaria Bioscience's Capital Leases fell 1972.05% to $109319.0 in Q3 2024 from the same period last year, while for Aug 2024 it was $109319.0, marking a year-over-year decrease of 1972.05%. This contributed to the annual value of $109319.0 for FY2024, which is 1972.05% down from last year.
- Lexaria Bioscience's Capital Leases amounted to $109319.0 in Q3 2024, which was down 1972.05% from $115327.0 recorded in Q2 2024.
- In the past 5 years, Lexaria Bioscience's Capital Leases ranged from a high of $142587.0 in Q2 2023 and a low of $7401.0 during Q3 2022
- In the last 3 years, Lexaria Bioscience's Capital Leases had a median value of $122486.0 in 2024 and averaged $108972.9.
- Per our database at Business Quant, Lexaria Bioscience's Capital Leases surged by 173992.7% in 2023 and then tumbled by 1972.05% in 2024.
- Over the past 3 years, Lexaria Bioscience's Capital Leases (Quarter) stood at $7401.0 in 2022, then surged by 1649.99% to $129517.0 in 2023, then decreased by 15.59% to $109319.0 in 2024.
- Its Capital Leases stands at $109319.0 for Q3 2024, versus $115327.0 for Q2 2024 and $122486.0 for Q1 2024.